| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |